Alpha Cognition, Inc. (ACOG)
9.12
+0.29
(+3.28%)
USD |
NASDAQ |
Sep 21, 16:00
9.12
0.00 (0.00%)
After-Hours: 20:00
Alpha Cognition Shareholders Equity (Quarterly) : 52.96M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.96M |
| March 31, 2026 | 57.46M |
| December 31, 2025 | 62.53M |
| September 30, 2025 | 33.91M |
| June 30, 2025 | 31.90M |
| March 31, 2025 | 40.81M |
| December 31, 2024 | 41.46M |
| September 30, 2024 | -2.920M |
| June 30, 2024 | -1.394M |
| March 31, 2024 | 0.1849M |
| December 31, 2023 | -4.713M |
| September 30, 2023 | -6.138M |
| June 30, 2023 | -0.4705M |
| March 31, 2023 | 1.318M |
| Date | Value |
|---|---|
| December 31, 2022 | -1.320M |
| September 30, 2022 | 1.775M |
| June 30, 2022 | 4.163M |
| March 31, 2022 | 6.853M |
| December 31, 2021 | 9.030M |
| September 30, 2021 | 1.422M |
| March 31, 2021 | -1.299M |
| January 31, 2021 | 0.4437M |
| January 31, 2020 | 0.6206M |
| October 31, 2019 | 0.6244M |
| July 31, 2019 | 0.632M |
| April 30, 2019 | 0.64M |
| January 31, 2019 | 0.6606M |
| October 31, 2018 | 0.4412M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | 1.026B |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 64.52M |
| Total Liabilities (Quarterly) | 11.56M |
| Current Ratio | 8.998 |